Pablo Berlanga

1.1k total citations
54 papers, 492 citations indexed

About

Pablo Berlanga is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Pablo Berlanga has authored 54 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Pablo Berlanga's work include Sarcoma Diagnosis and Treatment (24 papers), Neuroblastoma Research and Treatments (11 papers) and Cancer therapeutics and mechanisms (9 papers). Pablo Berlanga is often cited by papers focused on Sarcoma Diagnosis and Treatment (24 papers), Neuroblastoma Research and Treatments (11 papers) and Cancer therapeutics and mechanisms (9 papers). Pablo Berlanga collaborates with scholars based in France, Spain and Italy. Pablo Berlanga's co-authors include Victoria Castel, Adela Cañete, Jaime Font de Mora, Vanessa Segura, Hugo Sandoval, Donald E. Moss, Nadège Corradini, Chiho Ishida, Miriam Hagan and J. Antoni Sirerol and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Pablo Berlanga

47 papers receiving 483 citations

Peers

Countries citing papers authored by Pablo Berlanga

Since Specialization

Citations

This map shows the geographic impact of Pablo Berlanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Berlanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Berlanga more than expected).

Fields of papers citing papers by Pablo Berlanga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Berlanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Berlanga. The network helps show where Pablo Berlanga may publish in the future.

Co-authorship network of co-authors of Pablo Berlanga

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Berlanga. A scholar is included among the top collaborators of Pablo Berlanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Berlanga. Pablo Berlanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leukoencephalopathy, a Frequent Complication After High‐Dose Methotrexate in Treatment of Osteosarcoma 2025 ·Pediatric Blood & Cancer ·(unknown), (unknown), (unknown), Brice Fresneau, Nathalie Gaspar, Pablo Berlanga, Virginie Kieffer, (unknown), (unknown), (unknown), (unknown), Laurence Brugières, Blanche Bapst	0
2	Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium 2025 ·JCO Precision Oncology ·(unknown), A. Felix, (unknown), (unknown), Mehdi Brahmi, Nathalie Gaspar, Susanne A. Gatz, Thomas G. P. Grünewald, (unknown), Emanuela Palmerini, Pan Pantziarka, Sandra J. Strauss, Didier Surdez, Pablo Berlanga, Martin G. McCabe	0
3	Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study 2025 ·Pediatric Blood & Cancer ·Claudia Pasqualini, Stéphanie Proust, Gudrun Schleiermacher, Marion Gambart, (unknown), Arnaud Petit, (unknown), Estelle Thébaud, Yves Réguerre, (unknown), (unknown), Anne Sophie Defachelles, Pablo Berlanga	0
4	Radiothérapie des sarcomes d’Ewing 2025 ·Bulletin du Cancer ·L. Claude, Sylvie Helfré, Nadège Corradini, Nathalie Gaspar, Pablo Berlanga, Laure Saumet, Perrine Marec‐Bérard, Cyril Lervat, M. Ropars, Sophie Piperno‐Neumann, (unknown), (unknown), Anne Ducassou, (unknown)	0
5	Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy 2023 ·Cancers ·(unknown), (unknown), Luis Sendra, Salvador F. Aliño, Pablo Berlanga, (unknown), David Hervás, Julia Balaguer, (unknown), (unknown), Adela Cañete, María José Herrero	2
6	Clinical characteristics and outcomes for children, adolescents and young adults with “CIC‐fused” or “BCOR‐rearranged” soft tissue sarcomas: A multi‐institutional European retrospective analysis 2023 ·Cancer Medicine ·Monika Sparber‐Sauer, Nadège Corradini, Maria Carmen Affinita, Giuseppe Maria Milano, Gaëlle Pierron, Matthieu Carton, Franck Tirode, Daniel Pissaloux, Rita Alaggio, Christian Vokuhl, Gianni Bisogno, Pablo Berlanga, Andrea Ferrari, Daniel Orbach	10
7	Metastatic adult‐type non‐rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group 2023 ·Cancer ·Andrea Ferrari, Daniel Orbach, Michela Casanova, Max M. van Noesel, Pablo Berlanga, Bernadette Brennan, Nadège Corradini, Reineke A. Schoot, Gema Ramírez, Lisa Lyngsie Hjalgrim, Rita Alaggio, Gabriela Guillén, Akmal Safwat, Alison Cameron, Rick R. van Rijn, Véronique Minard‐Colin, Ilaria Zanetti, Gianni Bisogno, Julia Chisholm, Johannes H. M. Merks	7
8	Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation 2023 ·Nature Medicine ·Birgit Geoerger, Manuel Schiff, Virginie Penard‐Lacronique, Niklas Darín, (unknown), (unknown), Antonin Lamazière, (unknown), Clément Pontoizeau, Pablo Berlanga, Stéphane Ducassou, Katharine Yen, Michael Su, David P. Schenkein, Chris Ottolenghi, Stéphane de Botton	5
9	Oral vinorelbine in young patients with desmoid-type fibromatosis 2023 ·Tumori Journal ·(unknown), Daniel Orbach, (unknown), Hervé J. Brisse, Pablo Berlanga, Anne Sophie Defachelles, L Mansuy, Cécile Verite, Laure Saumet, Marie Karanian, Nadège Corradini	2
10	Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience 2023 ·Pediatric Blood & Cancer ·Pablo Berlanga, Daniel Orbach, Reineke A. Schoot, Michela Casanova, Rita Alaggio, Nadège Corradini, Bernadette Brennan, Gema Ramírez, Lisa Lyngsie Hjalgrim, Julia Chisholm, Gianni Bisogno, (unknown), Akmal Safwat, Johannes H. M. Merks, Gabriela Guillén, Max M. van Noesel, Andrea Ferrari	3
11	Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives 2023 ·Cancer Management and Research ·Andrea Ferrari, Pablo Berlanga, Susanne A. Gatz, Reineke A. Schoot, Max M. van Noesel, (unknown), Stefano Chiaravalli, Luca Bergamaschi, Véronique Minard‐Colin, Nadège Corradini, Rita Alaggio, Patrizia Gasparini, Bernadette Brennan, Michela Casanova, Sandro Pasquali, Daniel Orbach	4
12	Malignant ectomesenchymoma in children: The European pediatric Soft tissue sarcoma Study Group experience 2022 ·Pediatric Blood & Cancer ·Giuseppe Maria Milano, Daniel Orbach, Michela Casanova, Pablo Berlanga, Reineke A. Schoot, Nadège Corradini, Bernadette Brennan, Gema Ramírez, Lisa Lyngsie Hjalgrim, Max M. van Noesel, Rita Alaggio, Andrea Ferrari	2
13	Epithelioid hemangioendothelioma in children: The European Pediatric Soft Tissue Sarcoma Study Group experience 2022 ·Pediatric Blood & Cancer ·Daniel Orbach, Max M. van Noesel, Bernadette Brennan, Nadège Corradini, Rita Alaggio, (unknown), Reineke A. Schoot, Pablo Berlanga, Ilaria Zanetti, Lisa Lyngsie Hjalgrim, (unknown), Gema Ramírez, Michela Casanova, Andrea Ferrari	4
14	Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma 2021 ·Neuro-Oncology Advances ·(unknown), Jacob Torrejón, Dulanjalee Kariyawasam, Pablo Berlanga, Léa Guerrini‐Rousseau, Olivier Ayrault, Pascale Varlet, (unknown), Stéphanie Puget, Stéphanie Bolle, Kévin Beccaria, Thomas Blauwblomme, Laurence Brugières, Jacques Grill, Birgit Geoerger, Christelle Dufour, Samuel Abbou	12
15	Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network 2021 ·Bulletin du Cancer ·Emmanuelle Bompas, (unknown), (unknown), Maud Toulmonde, Perrine Marec‐Bérard, L. Claude, Françoise Ducimetière, Cyrus Chargari, Véronique Minard‐Colin, Nadège Corradini, Valérie Laurence, Sophie Piperno‐Neumann, Anne Sophie Defachelles, V. Bernier, Antoîne Italiano, Daniel Orbach, Jean‐Yves Blay, Nathalie Gaspar, Pablo Berlanga	5
16	Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas 2021 ·Journal of Personalized Medicine ·(unknown), (unknown), Pablo Berlanga, Vanessa Segura, Yania Yáñez, (unknown), (unknown), (unknown), Jaime Font de Mora, Victoria Castel, Adela Cañete	5
17	First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial 2021 ·European Journal of Cancer ·Raphael J. Morscher, (unknown), Pablo Berlanga, Lynley V. Marshall, Nicolás André, (unknown), Isabelle Aerts, Émilie De Carli, Nadège Corradini, (unknown), Xavier Paolettí, Peter G. Mortimer, Ludovic Lacroix, Gaëlle Pierron, Gudrun Schleiermacher, Gilles Vassal, Birgit Geoerger	24
18	Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project 2018 ·Clinical & Translational Oncology ·(unknown), Pablo Berlanga, G. Schreier, (unknown), Barbara Brunmair, Victoria Castel, Samira Essiaf, Adela Cañete, Ruth Ladenstein	5
19	Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition 2017 ·Clinical Cancer Research ·Elena Sanmartín, (unknown), Marta Piqueras, J. Antoni Sirerol, Pablo Berlanga, Adela Cañete, Victoria Castel, Jaime Font de Mora	29
20	El nuevo reto en oncología: la secuenciación NGS y su aplicación a la medicina de precisión 2016 ·Anales de Pediatría ·(unknown), Laia Pedrola, Pablo Berlanga, (unknown), Dolors Sánchez-Izquierdo, Adela Cañete, José Cervera, José M. Millán, Victoria Castel	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact